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JC polyomavirus (JCV) is an important human pathogen that causes the fatal demyelinating disease
progressive multifocal leukoencephalopathy (PML). In this study we further delineate the early events
of JCV entry in human glial cells and demonstrate that a pentameric subunit of the viral capsid is able to
recapitulate early events in viral trafﬁcking. We show that JCV trafﬁcs to the endoplasmic reticulum
(ER) by 6 h post infection, and that VP1 pentamers arrive at the ER with similar kinetics. Further, this
JCV localization to the ER is critical for infection, as treatment of cells with agents that prevent ER
trafﬁcking, ER function, or ER quality control reduce JCV infectivity. These pentamers represent a
new tool to study polyomavirus entry, and will be particularly useful in studying recently identiﬁed
polyomaviruses that are difﬁcult to propagate.
& 2012 Elsevier Inc. All rights reserved.Introduction
JC polyomavirus (JCV) is the causative agent of the fatal
demyelinating disease progressive multifocal leukoencephalopa-
thy (PML). Infection likely occurs in early to late childhood, with
50–80% of the population seropositive by early adulthood (Egli
et al., 2009; Kean et al., 2009; Knowles et al., 2003). JCV infects
cells of the kidney, bone marrow and lymphoid tissue (reviewed
in (Monaco et al., 1996; Randhawa et al., 2005; Tan et al., 2009;
Tan and Koralnik, 2010) resulting in a persistent, lifelong infec-
tion. In most healthy individuals, viral replication remains low,
resulting in an asymptomatic infection. In immunosuppressed
individuals however, especially HIV/AIDS patients, a dramatic
increase in viral replication occurs, resulting in lytic infection of
oligodendrocytes that is uniformly fatal (Tan and Koralnik, 2010).
Importantly, patients undergoing immunomodulatory therapies
have also been shown to develop PML as a result of reduced
immune function (reviewed in Major, 2010).
JCV is a nonenveloped virus containing a double stranded DNA
genome. The viral capsid is approximately 40 nm in diameter and
is composed of three structural proteins; VP1, VP2 and VP3. Five
VP1 molecules oligomerize to form the viral pentamer, and 72 of
these pentamers are linked through elongated C-terminal exten-
sions to form the viral capsid. VP2 and VP3 insert into the axial
cavity beneath VP1 and are sequestered from the exterior of thell rights reserved.
. Atwood).virion (Chen et al., 1998). A truncated form of VP1 that lacks the
C-terminal residues can be expressed in bacteria, and produces
VP1 pentamers that are unable to assemble into capsids (Neu
et al., 2010). These pentamers likely bind cell surface receptors
with similar afﬁnity to the intact virions, but bind cells with less
avidity due to the lack of valency of the intact capsid (Ewers and
Helenius, 2011; Neu et al., 2010; Neu et al., 2008).
JCV binds to cells using the receptor moiety lactoseries tetra-
saccaride series c (LSTc) and the serotonin receptor 5HT2A
(Elphick et al., 2004; Neu et al., 2010). LSTc contains an a2,6-
linked sialic acid, resulting in an ‘‘L’’ shaped conformation.
Binding to LSTc is highly speciﬁc, as JCV does not bind the closely
related carbohydrates LSTb and sialylparagloboside. Unlike most
polyomaviruses that bind gangliosides and are endocytosed by
non-clathrin dependent mechanisms, JCV is ﬁrst endocytosed by
clathrin-mediated endocytosis before entering the classical endo-
cytic pathway (Pho et al., 2000)(reviewed in Tsai and Qian, 2010).
Accordingly, treatment of cells with the clathrin mediated endo-
cytosis inhibitor chlorpromazine but not the caveolae dependent
endocytosis inhibitors nystatin or phorbol 12-myristate 13-acet-
ate reduces JCV infection, and cells expressing dominant-negative
constructs of the clathrin scaffolding adapter protein EPS15 will
reduce JCV infectivity (Pho et al., 2000; Querbes et al., 2004). After
endocytosis, JCV enters early endosomes and colocalizes with
the early endosomal marker Rab5 (Querbes et al., 2004). Cells
expressing dominant negative inhibitors of Rab5 or treated with
drugs that prevent endosomal acidiﬁcation prevents infection
(Ashok and Atwood, 2003; Querbes et al., 2006). Conversely,
treatment of cells with dominant-negative inhibitors against late
endosome (Rab7) or recycling endosome (Rab11)-speciﬁc proteins
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et al., 2006). JCV also appears to trafﬁc along microtubules and
microﬁlaments, as treatment of host cells with nocodozole and
cytochalasin D prevents infection (Ashok and Atwood, 2003). The
related polyomaviruses mouse polyomavirus (mPy) and simian
virus 40 (SV40) have been shown to trafﬁc to the ER and engage
various host-cell chaperones, resulting in destabilization of the
viral capsid (Magnuson et al., 2005; Rainey-Barger et al., 2007;
Schelhaas et al., 2007). Following localization to the ER, SV40, mPy
and BK polyomavirus (BKV) interact with the endoplasmic reticu-
lum associated degradation (ERAD) pathway, resulting in retro-
translocation of the virion into the cytoplasm (Inoue and Tsai,
2011; Jiang et al., 2009; Lilley et al., 2006; Schelhaas et al., 2007).
JCV has been shown to colocalize with the ER marker calregulin,
and treatment of cells with brefeldin A (BFA), a drug that inhibits
COP1 vesicle formation, interferes with the trafﬁcking of early
endosomes, and function of the Golgi apparatus, reduces infection
(Querbes et al., 2006; Richards et al., 2002). This implies that
trafﬁcking to the ER is important for JCV infection. However, it
remains unclear whether JCV usurps the same quality control
machinery and ERAD pathways as mPy and SV40. In this paper,
we further deﬁne the infectious pathway of JCV in transformed
human glial cells. We show that JCV trafﬁcs to the ER by 4–6 h
post-infection, similar to SV40 (Pelkmans et al., 2001; Schelhaas
et al., 2007). Additionally, siRNA knock down of ER quality control
machinery proteins and the ERAD-associated proteins decreases
infection, suggesting that these ER components are important for
infection. Finally, we show that JCV VP1 pentamers trafﬁc to the
ER with similar kinetics to the intact virion, demonstrating the
importance of the VP1 pentamer in early events of the polyoma-
virus replication cycle. This work highlights the importance of JCV
trafﬁcking to the ER, despite differences in early entry events from
other polyomaviruses. Further, our data show that pentameric VP1,
in the absence of the complete virion, is sufﬁcient to recapitulate
these trafﬁcking events.Fig. 1. Characterization of labeled JCV virions and pentamers. (A) Puriﬁed virions
(JCV) or pentamers (VP1) were labeled with Alexa Fluor 488 or 633 and resolved
by SDS-PAGE and imaged by ﬂuorography (top) or subsequently stained with
Coomassie G-250 (bottom). Closed arrowhead indicates VP1, open arrowhead
indicates a breakdown product of VP1, and asterisk indicates packaged histones.
(B) SVG-A cells were infected with equivalent amounts of labeled or unlabeled
virions and infected cells were quantitated at 72 hpi based on VP1 expression.
Data represent the average number of infected cells per ﬁeld for triplicate samples.
Error bars indicate standard deviations.Results
JCV virions and pentamers efﬁciently enter host cells
Following binding to cellular receptors, JCV enters cells by
clathrin-mediated endocytosis, a process that can be inﬂuenced by
receptor clustering (Liu et al., 2010). We ﬁrst sought to determine
whether the JCV virion, which contains 72 VP1 pentamers for a total
of 360 copies of VP1, may be endocytosed much more rapidly into
host cells than a less multivalent complex. To analyze the entry of
JCV into human glial cells (SVG-A), we labeled JCV virions with
either Alexa Fluor 488 (JCV-488) or Alexa Fluor 633 (JCV-633). To
test whether intact virions are more efﬁcient at entering cells, we
generated puriﬁed VP1 pentamers that do not assemble into
full virion-like particles, and labeled them with Alexa Fluor 488
(VP1-488) or Alexa Fluor 633 (VP1-633). SDS-PAGE and ﬂuoro-
graphic analysis indicate that VP1 is the major labeled protein for
both virions and pentamers, while Coomassie staining demonstrates
the purity of both labeled and unlabeled pentamers and virions
(Fig. 1A). Furthermore, single cycle growth assays reveal that the
infectivity of JCV was not adversely affected by labeling, as JCV-488
and JCV-633 were infectious and thus suitable for studies of JCV
infectious pathway (Fig. 1B).
Initial events in binding and entry of JCV virions or pentamers
were examined in SVG-A cells using confocal microscopy and
ﬂow cytometry. Labeled virus or pentamers were bound to cells at
4 1C and allowed to enter at 37 1C for speciﬁc time periods before
ﬁxation and imaging. At 0 min post binding, both JCV-488
and VP1-488 bound efﬁciently to cells, with the majority ofﬂuorescence localized at the plasma membrane (Fig. 2A). Two
hours after warming, the majority of virions and pentamers are
internalized into cells, with little signal remaining on the plasma
membrane. To quantify the amount of virus internalization,
the plasma membrane was outlined using the bright ﬁeld image,
and the percentage of ﬂuorescent signal on the plasma membrane
versus the cytoplasm was determined at each time point. At
0 min post binding, 70–80% of the ﬂuorescent signal is within the
plasma membrane region of interest. After 2 h at 37 1C, the
percentage of ﬂuorescence from both virus and pentamers at
the plasma membrane decreases where approximately 20% of
ﬂuorescence remains at the plasma membrane (Fig. 2B).
To further quantify the entry kinetics of virions and pentamers,
we used a trypan blue based quenching assay and assayed these
samples by confocal microscopy or ﬂow cytometry (Engel et al.,
2011; Rejman et al., 2004). Labeled pentamers or virions were
bound to pre-chilled cells and warmed to 37 1C for the indicated
times before ﬁxation. Trypan blue will quench plasma membrane-
associated Alexa Flour 488 ﬂuorescence but not internalized
ﬂuorophores, resulting in a direct readout of plasma membrane-
associated JCV or VP1. In chilled cells, all of the ﬂuorescence is
Fig. 2. JCV virions and pentamers bind and enter SVG-A cells with similar kinetics. (A) Pre-chilled SVG-A cells were inoculated with JCV-488 or VP1-488 pentamers for 1 h
at 4 1C. Cells were washed and ﬁxed at 0 min or incubated at 37 1C for 120 min before ﬁxation. Fixed samples were stained with DAPI before imaging by confocal
microscopy. Shown is either the ﬂuorescence image alone (left), or the ﬂuorescence signal overlaid onto the bright ﬁeld image (right). Scale bars¼10 mm. (B) Quantiﬁcation
of A. The plasma membrane of each cell was outlined using the bright ﬁeld image, and the percentage of virus or pentamer ﬂuorescence intensity on the plasma membrane
compared to the entire cell was determined using MetaMorph imaging software for at least ten cells per sample. Error bars indicate standard deviation. (C). Virus or
pentamer was bound to cells as in A. Cells were washed and ﬁxed at 0 min or incubated at 37 1C for 120 min before ﬁxation. Cells were imaged by confocal microscopy
(left). Extracellular ﬂuorescence was then quenched with trypan blue and the same cells were re-imaged (right). Scale bars¼10 mm. (D) Quantiﬁcation of endocytosis of
virions and pentamers. SVG-A cells were detached and chilled prior to binding of JCV-488 or VP1-488 pentamers for 1 h at 4 1C. Cells were then ﬁxed or warmed to 37 1C
for the indicated time points before ﬁxation. Cells were then incubated with trypan blue and protected ﬂuorescence was assayed by ﬂow cytometry.
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quenching when cells are warmed to 37 1C for 2 h (Fig. 2C). To
further delineate the rate of protection from trypan blue quench-
ing, we used ﬂow cytometry to quantitate virus and pentamer
internalization. Entry kinetics using this ﬂow cytometry based
assay are similar to results obtained by confocal microscopy, and
demonstrate no appreciable difference between virions and pen-
tamers (Lakadamyali et al., 2006) (Fig. 2D).
JCV and VP1 pentamers localize to the ER
We next sought to deﬁne the kinetics of JCV virion and
pentamer trafﬁcking to the ER. JCV has previously been shown
to colocalize with the ER marker calregulin at 12 hpi, and for SV40and mPy, trafﬁcking to the ER and engagement of ER resident
quality control machinery has previously been shown to be
critical for infectivity (Querbes et al., 2006; Schelhaas et al.,
2007; Walczak and Tsai, 2011). To determine whether VP1
pentamers trafﬁc to the ER with similar kinetics to intact virions
we analyzed JCV-633 or VP1-633 colocalization with an ER
marker at speciﬁc times post-infection and post pentamer treat-
ment. We show that starting at 6 hpi, signiﬁcant colocalization
between both pentamers or virions and the ER was seen (Fig. 3A
and B). This colocalization was quantiﬁed using Manders’ coefﬁ-
cient of colocalization, using the coefﬁcient from the virus
channel to determine colocalization (Bolte and Cordelieres,
2006). Signiﬁcant increases in colocalization were observed for
both virions and pentamers over the time course of infection,
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more colocalization between VP1 and ER than for the intact virus,
suggesting that VP1may target the ER with more rapid kinetics than
the intact virus. At 10 hpi, this colocalization decreased for both
virions and pentamers (Fig. 3B). These data show that both JCV and
VP1 trafﬁc to the ER with similar kinetics, suggesting localization to
this compartment is critical for the infectious life cycle of JCV, and
also further highlighting the importance of the VP1 pentamer in
directing viral trafﬁcking to the ER.Chemical inhibitors of ER trafﬁcking and function decrease JCV
infection and viral trafﬁcking
To further delineate the importance of the ER in the JCV infectious
pathway, we infected SVG-A cells in the presence of pharmacological
agents that disrupt components of this trafﬁcking pathway. Cells
were pretreated with each drug then inoculated with JCV in the
presence of the drug. After 45 h, cells were stained for large T antigen
and infected nuclei were scored. To ensure that drug treatment did
not have cytotoxic effects on the cells treated, cell viability assays
were performed, and drugs were used at concentrations where there
was greater than 90% cell viability (data not shown).
Treatment of SVG-A cells with Brefeldin A (BFA) reduced virus
infectivity by 50% as compared to an untreated control (Fig. 4A).
BFA has been demonstrated to prevent viral trafﬁcking to the ER
for other polyomaviruses, and has also been shown to prevent
trafﬁcking of viruses through endosomes, suggesting that ER
trafﬁcking is important for JCV infectivity (Inoue and Tsai, 2011;
Richards et al., 2002). Thus, we sought to determine whether BFA
treatment of SVG-A cells affects ER trafﬁcking of JCV virions and
pentamers, or whether this inhibition of infection is due to off-
target effects. Pretreatment of SVG-A cells with BFA signiﬁcantly
reduces colocalization of either labeled virions or pentamers with
the ER marker at 6 hpi (Fig. 3D).
Treatment of SVG-A cells with thapsigargin, a drug that
reduces ER calcium ion concentrations and the affects the
unfolded protein response (Shmigol et al., 1995), signiﬁcantly
reduced JCV infectivity, providing further evidence that ER traf-
ﬁcking is critical for JCV infectivity (Fig. 4A). Additionally, DTT
pretreatment of SVG-A cells also effectively inhibits JCV infection,
and likely inhibits cellular enzymes present in the ER (Fig. 4A)
(Schelhaas et al., 2007). These data suggest that upon arrival to
the ER, JCV is likely engaging enzymes that are inhibited by
thapsigargin or DTT treatment. Upon delivery to the ER, inter-
pentmeric disulﬁde bond isomerization has been shown to be
important for mPy and SV40 infectivity. To test whether intact
disulﬁde bonds were necessary for virus infectivity, we incubated
JCV with DTT for 2 h at 37 1C, and then removed DTT from the
sample. This DTT pretreatment of virions was shown to have no
effect on infection, indicating that disruption of disulﬁde bondsFig. 3. JCV virions pentamers trafﬁc to the ER. SVG-A cells were transfected with
the ER marker Heme Oxygenase-CFP (CFP-HO, pseudocolored red). Cells were
inoculated with JCV-633 (A) or VP1-633 pentamers (B) (pseudocolored green) at
4 1C for 1 h. Cells were washed and then incubated at 371C for 6 h before ﬁxation.
Confocal micrograph images (left) and enlarged images (right) are shown to
demonstrate colocalization. (C) Quantiﬁcation of virion or VP1 pentamer coloca-
lization with CFP-HO. Virus or pentamer was bound to pre-chilled cells for 1 h at
4 1C. Cells were then washed and ﬁxed, or warmed to 37 1C for the indicated time
points prior to ﬁxation. Colocalization was determined using Manders’ coefﬁcient
of colocalization. Error bars indicate standard deviation. npo0.05. (D) ER coloca-
lization after BFA treatment. SVG-A cells on coverslips were left untreated or
pretreated for 1 h with BFA. Cells were chilled to 4 1C and inoculated with JCV-633
or VP1-633 in the presence of BFA for 1 h at 4 1C. Cells were washed and either
ﬁxed or warmed to 37 1C for 6 h before ﬁxation and imaging. Manders’ coefﬁcient
of colocalization was determined for virions and CFP-HO. Error bars indicate
standard deviation. npo0.05. (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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need for free sulfhydryl during infection, we incubated JCV with the
alkylating agent 4-acetamido-40-maleimidylstilbene-2,20-disulfo-
nic acid (AMS) for 2 h at 371C, removed the AMS, and infected cells.
AMS will alkylate free cysteines, preventing disulﬁde bond isomer-
ization by the host cell ER isomerases. This pretreatment reduced
infection to 20% of our untreated control, demonstrating that freeTable 1
siRNAs used in this paper.
siRNA siRNA #1
product number
siRNA #2
product nu
Erp57 SI02654771 SI02654778
PDI SI00092414 SI03109680
Erp29 SI00317702 SI03153829
Erp72 SI03078236 SI00069916
Sel1 SI02664494 SI03035564
Derlin1 SI02778783 SI00135940
Derlin2 SI00362789 SI00362796
All stars (þ) control SI00135940 N/A
All stars () control SI00135940 N/A
ND¼Not determined.
Fig. 4. Reduction of JCV infectivity by chemical inhibitors. (A) SVG-A cells were
pretreated with inhibitors for 1 h, infected with JCV, then incubated in media
containing inhibitors for 45 h. Cells were ﬁxed and stained by indirect immuno-
ﬂuorescence using a monoclonal antibody to large T antigen and relative
infectivity compared to an untreated control was determined. Error bars denote
standard deviation. npo0.05 as compared to the untreated control. (B) Effect of
virion disulﬁde bond reduction or alkylation on infectivity. JCV virions were
pretreated with DTT to reduce disulﬁde bonds, or AMS to alkylate free disulﬁde for
2 h at 37 1C. DTT or AMS was then removed from the sample and equivalent
amount of virions were then added to SVG-A cells. Results are averaged from three
independent experiments. npo0.05 as compared to the untreated control.disulﬁdes are needed for productive infection (Fig. 4B). Thus, upon
arrival to the ER, JCV interacts with ER resident enzymes, and
alkylation of free disulﬁdes in the virion reduces infection
Speciﬁc ER enzymes are necessary for productive JCV infection
Upon reaching the ER, productive infection of host cells by SV40
and mPy has been shown to require the ER chaperones PDI, ERP57,
ERP72, and additionally ERP29 for mPy, (Gilbert et al., 2006;
Magnuson et al., 2005; Schelhaas et al., 2007; Walczak and Tsai,
2011). Since JCV also trafﬁcs to the ER, we tested whether these
proteins were important for JCV infection using a siRNA based
approach (Table 1). Following treatment of SVG-A with at least
2 different siRNAs per gene, cells were infected with JCV for 48 h,
before ﬁxation and indirect immunoﬂuorescence staining for large T
antigen. Knockdown of the thio-reductase proteins ERp57, PDI, and
ERP72 resulted in a signiﬁcant reduction of JCV infectivity (Fig. 5A).
Additionally, knockdown of the disulﬁde isomerase ERP29 reduced
JCV infectivity. siRNA treatment signiﬁcantly reduced targeted
protein levels, as compared to cells treated with a negative control
siRNA (Fig. 5B). Additionally, we show that knockdown of the ERAD
associated protein Sel1, but not Derlin-1 or Derlin-2 also signiﬁ-
cantly reduced JCV infectivity. For Derlin-2 and Sel1L, RT-PCR
analysis demonstrated that mRNA levels of targeted genes were
reduced to levels less than 25% of cells treated with control siRNA
(Fig. 5C). These data indicate that after trafﬁcking to the ER, JCV
utilizes the ERAD pathway for productive infection.
VP1 pentamers do not localize to the golgi apparatus
The pentameric subunit of JCV shares a high degree of
structural similarity with the B subunit of cholera toxin, which
undergoes retrograde trafﬁcking to the golgi apparatus prior to
trafﬁcking to the ER (reviewed in Lencer and Tsai, 2003; Sandvig
and van Deurs, 2005). To investigate whether JCV virus or
pentamers also trafﬁc to the golgi, we bound Alexa Fluor 488
labeled cholera toxin B-subunit (CTB-488), VP1-488, or JCV-488
to SVG-A cells and immunostained the golgi apparatus. Using
confocal microscopy, colocalization was observed between the
Golgi and CTB-488 starting at 0.5 hpi, with signiﬁcant colocaliza-
tion of CTB-488 at 6 hpi (Fig. 6). Conversely, JCV and VP1 appear
to localize in organelles adjacent to the Golgi apparatus, but at no
time points do we see colocalization between virus or pentamers
and the golgi apparatus (Fig. 6).Discussion
Polyomavirus entry is a complex process that requires viral
engagement of numerous host-cell factors in multiple cellularmber
Concentration (nM) Antibody
20 Enzo (ADI-SPA-585)
200 Enzo (ADI-SPA-890)
10 Abcam (ab11420)
10 Enzo (ADI-SPS-720)
100 ND
50 Abcam (ab54545)
50 ND
50 ND
50 ND
Fig. 5. siRNA knockdown of ER proteins reduces JCV infectivity. SVG-A cells were
reverse transfected with at least two siRNAs of the indicated gene or scrambled
siRNA. At 72 h post-transfection, cells were infected with JCV, ﬁxed and at 45 hpi,
and stained with a monoclonal antibody to large T antigen. Results are the average
of three independent experiments and error bars denote standard deviations.
(B) SVG-A cells were transfected with each siRNA as in A. Cell lysates were
collected at 72 hpi and analyzed by SDS-PAGE and immunoblotting with anti-
bodies to each targeted protein or GAPDH. SVG-A cells transfected with scrambled
siRNA was used as a negative control for normal protein levels. (C) RT-PCR
quantiﬁcation of targeted mRNA levels after siRNA knockdown. SVG-A cells were
transfected with indicated siRNA. 72 h post transfection, cells were harvested and
DDCt values of each gene were calculated relative to GAPDH. These levels were
then compared to a control which was transfected with negative control siRNA.
Results are the average of three independent experiments. Error bars indicate
standard deviation.
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pathway of JCV in human glial cells and establish the VP1 pentamer
of JC virus as a powerful tool for studying the early events of
polyomavirus trafﬁcking. Puriﬁed JCV pentamers recapitulate the
early trafﬁcking steps of the complete virus, from attachment and
entry through localization to the ER. We also show that ER
trafﬁcking is critical for infection by disrupting major ER functions
using either drug treatment or siRNA knockdown. These results
demonstrate VP1 can be used as a model for studying JC virus
infection as well as the infectious life cycle of the newly-discovered
and difﬁcult to cultivate human polyomaviruses.
The initial interaction between JCV and host cells is mediated by
VP1 binding to an a-2,6 linked sialic acid moiety present on LSTc,
and the serotonin receptor 5HT2A (Elphick et al., 2004; Neu et al.,
2010). Using confocal microscopy, we show entry of both virions
and pentamers is rapid, with the majority of VP1 being endocytosed
by 30 min (Fig. 2). This rapid entry is consistent with clathrin-
mediated endocytosis (Lakadamyali et al., 2006). Although clathrin-
mediated endocytosis is a constitutive process, it has been reported
that clustering of receptor cargo can increase the rate of endocytosis
(Liu et al., 2010). We found no measureable differences in the
kinetics of entry between virions and pentamers, indicating that
the increased multivalency of the intact virion does not increase
endocytosis rates in SVG-A cells (Fig. 2).
VP1 pentamers also trafﬁc to the ER, demonstrating that
successful trafﬁcking of JCV to the ER can be orchestrated by
this small subunit (Fig. 3A). To quantify colocalization we used
Manders’ coefﬁcient of colocalization, which will allow for colo-
calization measurements to be performed when differences in
ﬂuorescence intensities exist between the two acquired channels.
This coefﬁcient corresponds to the ratio of summed intensities of
pixels in the virus channel for which ER ﬂuorescence is above zero
to the total intensity in the virus channel and has a maximum
value of 1 (Bolte and Cordelieres, 2006). Since only a small
proportion of virions or pentamers are successfully targeted to
the ER, we observe coefﬁcients of 0.3, verifying that ER targeting
is an inefﬁcient process. Surprisingly, we see more colocalization
between VP1 and the ER at 2 hpi than for intact virus, suggesting
that the small pentamer targets the ER with increased kinetics
(Fig. 3B). The colocalization between the VP1 pentamer and the
ER-speciﬁc marker CFP-HO suggests that JCV VP1 ER trafﬁcking is
strikingly similar to the ER targeting of bacterial toxins including
cholera and Shiga toxin. Entry and ER targeting of cholera toxin
has been extensively studied, and careful studies have also been
performed comparing the ER trafﬁcking of SV40 and mPy to
cholera toxin (reviewed in Ewers and Helenius, 2011; Johannes
and Popoff, 2008; Johannes and Wunder, 2011; Tsai and Qian,
2010). In the case of mPy and likely other polyomaviruses, ER
trafﬁcking is a direct result of ganglioside binding and choles-
terol-dependent endocytosis (Qian et al., 2009). As exempliﬁed
for cholera toxin, the binding of 5 ganglioside molecules alone is
sufﬁcient to direct the toxin to the ER. This is in contrast to the
trafﬁcking patterns of antibodies to the ganglioside GD3, which
were found to recycle to the plasma membrane rather than trafﬁc
to the ER (Crespo et al., 2008). However, JCV has very low afﬁnity
for gangliosides, and instead requires serotonin receptor 5HT2A
(Elphick et al., 2004) and the sialic acid motif LSTc (Neu et al.,
2010) to enter cells by clathrin-mediated endocytosis. It is there-
fore unclear whether the JCV VP1 pentamer or virus trafﬁcs to the
ER in a similar fashion to bacterial toxins or other polyoma-
viruses, especially since Rab7 dominant negative constructs do
not inhibit JCV infection, unlike SV40 or mPy (Querbes et al.,
2004). Since receptor binding plays a major role in ER targeting of
endocytosed cargo and multiple retrograde pathways targeting
the ER have been characterized, identifying the proteinaceous
or lipid receptor molecule to which LSTc is attached will be
Fig. 6. JCV virions or pentamers do not trafﬁc to the golgi apparatus. Cells were chilled to 4 1C inoculated with JCV-488, VP1-488 pentamers, or CT-B-488 (green) for 4 1C
for 1 h. Cells were then ﬁxed or warmed to 37 1C for the indicated time points prior to ﬁxation. Cells were stained with an antibody against the golgi marker giantin (red)
and coverslips were mounted in mounting media containing DAPI (blue). Scale bars¼2 mm. (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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(Bonifacino and Hurley, 2008; Johannes and Popoff, 2008;
Johannes and Wunder, 2011; Popoff et al., 2007; Rojas et al.,
2008).
Confocal microscopy and pharmacological inhibitor studies
demonstrate that trafﬁcking to the ER is a critical step for JCV
infection, and thus validates a model whereby JC pentamers
trafﬁc to this compartment. Previous studies have demonstrated
that JCV colocalizes with the ER marker calregulin at 12–16 hpi
and treatment of SVG-A cells with BFA reduces infection (Querbes
et al., 2004). To verify that JCV ER targeting is critical to infectivity
and that BFA is not preventing infection due to off target effects,
we undertook a pharmacological and siRNA based approach to
reduce ER function. We show that treatment of cells with BFA,
which inhibits COP1 vesicle formation, not only reduces infection,
but also prevents JCV from trafﬁcking to the ER (Fig. 5A). To
further stress the importance of the ER in JCV infection, we
treated cells with thapsigargin, a drug that interferes with ER
calcium ion homeostasis and the unfolded protein response. This
treatment signiﬁcantly reduced JCV infection (Fig. 4A). Addition-
ally, we show that DTT pretreatment of SVG-A cells, which has
been suggested to interfere with the function of resident ER
proteins, reduces JCV infectivity (Fig. 5E) (Schelhaas et al.,
2007). That DTT pretreatment of cells acts on cellular factors
and not virions is consistent with our results demonstrating that
DTT pretreatment of virions does not reduce infection (Fig. 5E).
Thus, our pharmacological data strongly demonstrates that JCV
trafﬁcs to the ER, and interference either with ER trafﬁcking, or
with ER function, signiﬁcantly reduces JCV infectivity.
To further delineate what ER factors are utilized by JCV during
infection, we employed a siRNA based approach to speciﬁcally
knock down individual ER chaperones. We show that siRNA
mediated knockdown of PDI, ERp29, ERp57, and ERp72 reduces
JCV infectivity (Fig. 5A). Similar to mPy but unlike SV40, siRNA
mediated knockdown of ERp29 reduces JCV infectivity. ERp29
contains only a single cysteine and therefore can isomerize but
not disrupt disulﬁde bonds, demonstrating that isomerization of
JCV disulﬁde bonds is critical to infection (Hebert and Molinari,
2007). While siRNAs targeting PDI signiﬁcantly reduced infectiv-
ity, appreciable levels of PDI remained after this treatment
(Fig. 5b). It is possible that our siRNAs to PDI are resulting in off
target effects, however the requirement for PDI in JCV infectivity
is consistent with other poylomaviruses. The importance ofcapsid disulﬁde bond isomerization during infection is consistent
with our results that alkylation of JCV free cysteine residues in the
viral capsid reduces infection (Fig. 4E) (Magnuson et al., 2005). In
recent studies on mPy, PDI and Erp57 were shown to act in a
coordinated fashion to partially disassemble the viral capsid
(Walczak and Tsai, 2011). Thus it is likely that upon arrival to
the ER, JCV engages a number of these PDI family members in a
similar fashion to SV40 and mPy to disrupt the interpentameric
disulﬁde bonds. In SV40, cysteine 9 (C9) and C104 form inter-
pentameric disulﬁde bonds with adjacent pentamers to link the
capsid together, and a disulﬁde bond at C15 has been shown to be
important in mPy (Schelhaas et al., 2007; Walczak and Tsai,
2011). Cysteine residues 104 and 257 are conserved in JCV;
however, JCV lacks the C9, and likely engages these ER enzymes
in a similar, but not identical fashion. Additionally, knockdown of
Sel1 reduces infectivity. Sel1 is a component of the ERAD path-
way, suggesting that JCV may also use this retrotranslocation
pathway for productive infection. Surprisingly, siRNA knockdown
of either Derlin-1 or Derlin-2 fails to signiﬁcantly reduce JCV
infectivity (Fig. 5A). Even with high levels of siRNA, Derlin-1 or
Derlin-2 were present at low levels, as determined by western
blotting or RT-PCR. Therefore it is possible that the siRNAs used
do not reduce targeted proteins to a level where JCV infectivity
would be inhibited. Alternatively, JCV may interact with Sel1
independent of Derlin-1 or Derlin-2 for successful retrotransloca-
tion into the cytosol. This interaction has previously been
reported for the Sel1 mediated degradation of a mutant of
ribosome receptor protein ribophorin (Mueller et al., 2006).
Finally, we investigated whether JCV VP1 pentamers trafﬁc to
the golgi apparatus, similar to bacterial toxins. Polyomavirus VP1
pentamers contain a structure similar to AB5 toxins such as
cholera toxin (Chen et al., 1998; Sixma et al., 1991; Stehle and
Harrison, 1997). Both CTB and polyomaviruses undergo retro-
grade trafﬁcking to the ER; however, CTB rapidly trafﬁcs to the
golgi apparatus prior to arrival in the ER. Several possibilities exist
for what factors inﬂuence golgi localization. JCV pentamers bind
the receptor motif LSTc rather than cholera toxin’s receptor GM1,
and this interaction may dictate golgi trafﬁcking. Alternatively,
low avidity interactions between pentamers or toxins and its
receptor may direct trafﬁc to the golgi apparatus, whereas the
much higher avidity interaction between the intact virion and its
receptor may result in direct ER trafﬁcking. Finally, the larger size
of the virion compared to JCV VP1 pentamers or CTB may result in
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and our golgi marker giantin, we saw rapid accumulation of CTB
starting at 0.5 hpi, similar to previously published reports (Mallard
et al., 1998; Natarajan and Linstedt, 2004). However, we were
unable to visualize colocalization between JCV virus or pentamer
and the golgi apparatus occurs at time points up to 6 hpi, suggest-
ing that JCV and CTB may target the ER by different trafﬁcking
pathways. This result suggests that the speciﬁc receptor interac-
tions between VP1 pentamers or cholera toxin and its receptor may
dictate sorting to the golgi rather than the avidity of ligand receptor
interactions. It is possible that JCV pentamers may be sorted to the
golgi apparatus, but any targeting would either be much less
efﬁcient than cholera toxin or would be with drastically different
kinetics (time points after 6 hpi). Future studies are underway to
further delineate the requirements for golgi targeting.
In conclusion, we demonstrate that JCV trafﬁcs to the ER with
almost identical kinetics to the VP1 pentameric subunit of JC virus
alone. Once in the ER, JCV utilizes host-cell chaperones in a similar
fashion to mPy and SV40, demonstrating that targeting this orga-
nelle is critical for JCV infectivity. This study provides additional
insight into the infectious pathway for JCV in human glial cells, and
demonstrates that a subunit of the viral capsid can be utilized as a
tool to study viral entry and trafﬁcking pathways in viruses that are
difﬁcult to cultivate or for higher throughput assays.Materials and methods
Viruses, cells and plasmids
The MAD1-SVEn strain of JCV and the human fetal glial cell
line SVG-A maintained in complete growth media (1X MEM,
10%FBS, 0.5% penicillin, 0.5% streptomycin) were used for all
experiments (Major et al., 1985; Vacante et al., 1989). The CFP-
Heme Oxygenase 2 (CFP-HO) plasmid was a kind gift fromMelissa
Rolls (Pennsylvania State University). Rab5 fused to monomeric
red ﬂuorescent protein (Rab5-mRFP) and Rab7-mRFP were pur-
chased from Addgene (plasmid 14437 and 14436, respectively)
(Vonderheit and Helenius, 2005) and the Rab5-GFP and Rab7-GFP
were gifts from Stephen Furguson (Robart Research Institute) and
Craig Roy (Yale University).
Virus puriﬁcation and labeling
JCV was puriﬁed similar to previously published methods
(Shen et al., 2011). Brieﬂy, ten 1700 cm2 roller bottles were seeded
with SVG-A cells at 50% conﬂuency and infected with JCV at an MOI
of 0.1 FFU/cell for 14 day, with the cell culture media replaced at
7 day. Viral lysates were harvested by scraping cells in the presence
of cell culture media, and this lysate was frozen and thawed 3 times.
The lysate was then treated with type V neuraminidase (Sigma) at
37 1C for 1 h to release JCV still bound to cells. Deoxycholate acid
(Fisher Scientiﬁc) was added to further disrupt cells for 1 h at 37 1C
and then sonicated three times on ice (50% amplitude 50% duty cycle,
power 4, 1 min). The cellular debris was pelleted by centrifugation,
and the viral supernatant was pelleted through a 20% sucrose
cushion in a Beckman SW40ti rotor at 150,000g at 4 1C for 3 h. The
viral pellet was resuspended into buffer A (10 mM Tris–HCl, 50 mM
NaCl, 0.1 mM CaCl2) and sonicated 3 times (30% amplitude 50% duty
cycle, power 3, 1 min). The resuspended pellet was loaded onto a
CsCl step gradient (1.29–1.35 g/ml) and spun at 115,000g at 4 1C for
18 h in a Beckman SW55ti rotor. The band corresponding to DNA-
containing virions was isolated and dialyzed extensively against
buffer A. The dialyzed virus was further puriﬁed by size exclusion
chromatography over an S500HR column previously equilibrated in
Buffer A (GE Healthcare). The monomeric virus fraction was collectedand concentrated using an Amicon ultra-15 (Millipore) to approxi-
mately 0.2 mg/mL. Virion concentrations were determined by Brad-
ford assay. Viral proteins were resolved on a 4–15% gradient SDS-
PAGE gel (Bio-Rad) and stained with coomassie G250 (Sigma) to
ensure virus purity (Fig. 1). JCV was labeled with Alexa Fluor 488 or
Alexa Fluor 633 according to manufacturers’ instructions (Invitro-
gen). Brieﬂy, puriﬁed JCV was desalted in 0.1 M carbonate/bicarbo-
nate buffer pH 8 using a HiTrap 5mL column (GE Healthcare). The
virus was then concentrated to 0.5 mg/ml and dye was added at a
molar excess of 200:1. After 1 h of rocking incubation at room
temperature, the excess dye was removed over a HiTrap 5mL
column. To verify ﬂuorescence labeling, viral proteins were resolved
on a 4–15% SDS-PAGE gel and imaged using a Typhoon ﬂuorescence
imager (Fig. 1).
Pentamer puriﬁcation and labeling
JCV VP1 pentamers were puriﬁed as described previously (Neu
et al., 2010). Brieﬂy, a 2 L bacterial culture transformed with a
pET15-b bacterial expression vector containing JCV VP1 residues
22–289 were grown to an OD of 0.8 at 37 1C with shaking and
induced with 0.2 mM IPTG. Cultures were grown at 21 1C for 18 h
and the bacteria were pelleted. This pellet was resuspended in
20 mL of loading buffer (50 mM Tris–HCl, 250 mM NaCl, 10 mM
imidazole, 5% glycerol) and frozen in liquid nitrogen. After thawing,
the pellet was sonicated 5 times on ice and the bacterial lysate was
pelleted by low speed centrifugation. The supernatant was ﬁltered
through a 0.22 mm ﬁlter and puriﬁed using a HisTrap 5 mL column
using an AKTA Puriﬁer (GE Healthcare). Pentamers were eluted
from the column with a linear gradient of 10–500 mM imidazole,
and fractions corresponding to pentamers were collected and
dialyzed against 20 mM Tris base, 5% glycerol, 250 mM NaCl,
10 mM DTT. The sample was then concentrated and monomeric
VP1 pentamers were puriﬁed using a Superdex S200 column and
eluted in 20 mM Hepes Free acid, 150 mM NaCl, 50 mM DTT (GE
Healthcare). These monomeric pentamers were concentrated to
1 mg/ml, aliquoted and stored at 80 1C until use. Concentrations
of puriﬁed pentamers was determined by spectrophotometric
absorbance at 280 nm, using a molar extinction coefﬁcient of
28,0230 M1 cm1 per VP1 monomeric subunit. A thawed aliquot
of VP1 pentamers was re-puriﬁed by size exclusion chromatogra-
phy to ensure that the VP1 pentamers did not aggregate after
freezing and thawing. VP1 pentamers were labeled with Alexa
Fluor 488 or Alexa Fluor 633 as described above for JCV virions.
Treatment of cells with inhibitors
To determine the effects of inhibitors on JCV infectivity, SVG-A
cells were plated in 96-well plates at a density of 2104 cells/cm2
and incubated at 37 1C 16 h in complete growth media. One hour
prior to infection media was removed, and fresh media containing
the inhibitor (5 mM DTT, 0.25 mM thapsigargin, 5 ng/mL brefeldin
A) was added to cells. After 1 h, cells were infected with JCV at an
MOI of 1 FFU/cell in complete growth media containing 2% FBS
and allowed to bind for 1 h. Cells were then washed with fresh
media containing inhibitors, and incubated in media containing
inhibitors for 45 h. Cells were washed in PBS, ﬁxed in ice-cold
methanol, and stained with a primary monoclonal antibody
speciﬁc for JCV large T antigen (Pab962) and a secondary Alexa
Fluor 488 goat anti-mouse antibody for 1 h each (Invitrogen).
Infected cells were quantitated by counting 3 ﬁelds for each well,
for triplicate samples from three separate days. The infectivity
studies were only performed at concentrations where there was at
least 90% viability as compared to the positive control based on a
CellTiter 96 Aqueous One Solution Cell Proliferation Assay
(Promega).
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siRNAs were purchased from Qiagen (Table 1). 3105 SVG-A
cells in 24 well plates were transfected with siRNAs using siRNA
max lipofectamine transfection reagent according to manufacturer’s
guidelines (Invitrogen). SVG-A cells were reverse transfected by ﬁrst
mixing siRNA and transfection reagent in cell culture media, and
then overlaying cells to this mixture. Optimal siRNA concentrations
were either determined using ﬂuorescently labeled siRNA (Block-it,
Invitrogen), or were based on previously published concentrations
(Schelhaas et al., 2007). Two siRNAs per gene were transfected in
separate wells to ensure speciﬁcity of siRNAs. 72 h post transfection,
cells were either infected with JCV or harvested for western blot
analysis or realtime PCR (RT-PCR) analysis. Each well was infected
with JCV at an MOI of 1 FFU/cell at 37 1C for 1 h. After 1 h, unbound
virus was washed, and complete media was added to each well. At
48 hpi, cells were ﬁxed with MeOH and stained with PAB692.
Infectivity data were normalized as a percent infectivity of the
negative control (Allstars siRNA negative control, Qiagen). A cocktail
of siRNAs that are lethal to cells was used a positive control (Allstars
siRNA positive control, Qiagen). For western blot analysis, cells were
harvested at 72 h post siRNA transfection. Cells were washed with
PBS, detached with a cell scraper, pelleted by low speed centrifuga-
tion, and the supernatant was aspirated. The remaining cellular
pellet was incubated in RIPA buffer with protease inhibitors at 4 1C
for 30 min with constant rocking. Cellular debris was then pelleted
at 14,000g at 4 1C. The remaining supernatant was then resolved on
a 4–15% SDS-PAGE gel and transferred to PVDF membranes.
Membranes were blocked for 1 h, and incubated with the appro-
priate primary antibody for 1 h in blocking buffer according to the
manufacturer’s recommended guidelines (Table 1). A primary anti-
body against GAPDH was also used as a loading control (Sigma). The
membrane was washed in PBS-T (0.05% Tween-20), and a secondary
antibody conjugated to an infrared dye was added for 1 h. After
washing, the membrane was imaged using an Odyssey infrared gel
scanner (Li-Cor). For RT-PCR analysis, SVG-A cells were transfected
with Derlin-2 or Sel1 siRNAs as above. 72 h post transfection,
mRNAs were harvested from cell lysates using the Taqman Cells
to CT kit (Life Sciences). Reverse transcriptase and RT-PCR was
performed according to manufacturer’s guidelines, using prede-
signed probes speciﬁc for Derlin2, Sel1, or GAPDH (Life Sciences).
For PCR analysis, CT threshold levels were set, and the DCT values
between GAPDH and the gene of interest was determined. RT-PCR
was also performed using a negative control siRNA, and negative
control DCT values were determined, and used to generate DDCT
values for each experimental siRNA. Target mRNA levels remaining
were determined using the following equation: %mRNA remaining¼
100([1–2DDCT]100).
Confocal imaging of JCV entry
All microscopy experiments were performed using an LSM-
710 laser scanning confocal microscope with a 631.4NA plan
apochromat objective with the pinhole set to one Airy unit (Carl
Zeiss). DAPI and CFP-HO were excited using a 405 nm diode laser,
Alexa Fluor 488 was excited using a 488 nm argon laser and Alexa
Fluor 633 was excited using a 633 nm helium-neon laser. For
ﬁxed cell experiments, SVG-A cells were seeded overnight onto
#1.5 cover slips (Carl Zeiss). Cells were chilled at 4 1C to prevent
endocytosis, and 100 ng of labeled virus or pentamers were
bound for 1 h at 4 1C. Excess virus was washed and the samples
were returned to 37 1C for the speciﬁc length of time. Approxi-
mately 2500–5000 particles were bound per cell for these
experiments. Cells were ﬁxed with 4% paraformaldehyde (PFA)
and mounted in an aqueous media either containing or
lacking DAPI.Viral entry quenching experiments were performed as pre-
viously described (Engel et al., 2011). Brieﬂy, SVG-A cells were
seeded onto #1.5 coverslips. The following day, cells were pre-
treated with 15 ng/mL Brefeldin A at 37 1C for 1 h, or left
untreated. Cells were then chilled at 4 1C for 30 min and Alexa
Fluor 488 labeled JCV or pentamers was bound to cells at 4 1C for
1 h. The cells were then washed and ﬁxed with 4% PFA or warmed
to 37 1C for 2 h to allow internalization of virus prior to ﬁxation.
Prior to quenching of external ﬂuorescence with trypan blue, a
Z-stack of images was taken that imaged the entire height of the
cell. After quenching the same Z-series was reimaged, and these
images were combined into a single image projecting the max-
imal ﬂuorescence to demonstrate quenching.
For the golgi colocalization experiments, SVG-A cells were
seeded overnight onto #1.5 coverslips. Cells were then chilled at
4 1C for 30 min and 5 mg/ml of JCV-488, 20 mg/ml of VP1-488, or
10 mg/ml of CTB-488 was bound to cells at 4 1C for 1 h. The cells
were then washed and ﬁxed with 4% PFA or warmed to 37 1C for
the speciﬁed prior to ﬁxation. Cells were then permeabalized, with
1% triton X-100 and the golgi was stained with a rabbit polyclonal
antibody to the golgi marker giantin (Abcam) and an Alexa Fluor
594 labeled secondary antibody against rabbit. Cells were
mounted in aqueous mounting media containing DAPI and imaged
by confocal microscopy.
Image analysis of confocal microscopy
For analysis of JCV and viral pentamer entry into cells (Fig. 2B),
MetaMorph image analysis software was used (Molecular
Devices). The cell boundary of twenty individual cells was traced
as a region of interest based on the bright ﬁeld images. An
inclusive threshold was then applied to the ﬂuorescence signal
(representing either JCV or pentamer) and average pixel intensity
was calculated for that region and the entire cell. The percentage
of plasma-membrane associated ﬂuorescence signal was then
calculated. Background ﬂuorescence within each cell reduces
the percentage of total ﬂuorescence signal on plasma membrane.
In order to better deﬁne the ER boundaries, images were ﬁltered
using the Fast Fourier Transform Band pass ﬁlter as described
(Qian et al., 2009). Brieﬂy, the settings were speciﬁc for ﬁltering
structures down to 15 pixels and up to 3 pixels with a tolerance of
detection of 5%. Speciﬁc colocalized regions are shown as
enlarged insets at t¼0, t¼30 and t¼60, and at least 10 cells were
analyzed per sample. The images were FFT ﬁltered as described
above, and colocalization was assessed using the Manders’ coefﬁ-
cient (Bolte and Cordelieres, 2006). For Manders’ coefﬁcient of
colocalization, the coefﬁcient from the virus channel was used to
determine colocalization. Error represents standard deviation.
Quantiﬁcation of virus and pentamer endocytosis by ﬂow cytometry
To quantify endocytosis of virus and pentamers into SVG-A
cells, we employed a ﬂow cytometry based trypan blue quenching
assay (Engel et al., 2011; Rejman et al., 2004). Trypan blue is a cell
impermeant dye that will quench any Alexa Fluor 488 ﬂuoro-
phores attached to extracellular virus or pentamer. This allows
the determination of the rate of endocytosis, by measuring
the entry of labeled pentamers or virions into cells, which are
protected from quenching. SVG-A cells were seeded into six
welled plates and were incubated overnight. Cells were detached
from each well using cellstripper (Cellgro), and the cells were
washed in PBS. Cells were incubated in phenol red free MEM and
cooled to 4 1C to prevent endocytosis. Virus or pentamer were
then incubated with cells for 1 h on ice to allow binding. Cells
were extensively washed, and were then either immediately
analyzed by ﬂow cytometry, or heated to 37 1C to allow
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trypan blue quenching to determine the total levels of ﬂuores-
cence per cell. To quench extracellular ﬂuorescence, trypan blue
was added to each sample at a ﬁnal volume of 0.008% (V/V)
immediately before analysis by ﬂow cytometry. The level of
internalization (i) at each timepoint was determined by compar-
ing the ratio of ﬂuorescence of unquenched (Fq) and unquenched
(Fo) according to the following formula: i¼(Fq/Fo)n100.Acknowledgments
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